Article
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.
Molecular metabolism - 1 Aug 2021
Pafili Kalliopi, Roden Michael
Abstract excerpt
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) comprises hepatic alterations with increased lipid accumulation (steatosis) without or with inflammation (nonalcoholic steatohepatitis, NASH) and/or fibrosis in the absence of other causes of liver disease. NAFLD is developing as a burgeoning health challenge, mainly due to the worldwide obesity and diabetes epidemics. SCOPE OF REVIEW: This review summarizes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
